Billings Clinic
Especially For:

Clinical Trials

Title   Leukemia (S0535): Promyelocytic M3
Description   A Phase II Study of ATRA, Arsenic Trioxide and Gemtuzumab Ozafamin in Patients with Previously Untreated High-Risk Acute Promyelocytic Leukemia
IRB Number   SWOG S0535
Category   Leukemia
Inclusion/Notes   No prior chemotherapy except ATRA up to 3 days or Hydrea

Call Contact # below for further Inclusion/Exclusion criteria


Temporary Closure 10/2011
Status   Active
Start Date   12/14/2007
Principal Investigator (PI)   Jorge Nieva, MD
Physician Profile   Hematology/Oncology
Contact Name   Linda Allen RN
Contact Email   lallen@billingsclinic.org
Phone   (406) 435-7484
Alternate Phone   (406) 435-7480
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.